Skip to main content
Clinical Trials/EUCTR2010-020466-18-GB
EUCTR2010-020466-18-GB
Active, not recruiting
Not Applicable

Can periarticular knee injection of multimodal agents Levobupivicaine, Morphine, Ketorolac and adrenaline improve postoperative pain and function following primary total knee arthroplasty? - Periarticular infiltration following total knee arthroplasty

niversity of Warwick0 sitesAugust 18, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Warwick
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 18, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity of Warwick

Eligibility Criteria

Inclusion Criteria

  • All patients undergoing an elective primary unilateral total knee arthroplasty under the care of an orthopaedic consultant at University Hospitals Coventry and Warwickshire NHS trust will be eligible for the trial unless they fit the exclusion criteria.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • The following patients will not be eligible for entry to the trial:
  • Those with sufficient cognitive impairment that they would be unable complete questionnaire (cognitive impairment).
  • Those patients who lack capacity under the Mental Capacity Act 2005
  • Those patients with a pre\-operative history of neurological abnormality in the ipsilateral leg e.g. history of stroke, neurogenic pain or previous nerve injury.
  • Those patients having spinal anaesthesia.
  • Those patients with a specific contraindication to the analgesic agents used:
  • ?Hypersensitivity reaction
  • ?Active or previous peptic ulcer. History of upper gastrointestinal bleeding or perforation, related to previous NSAID therapy.
  • ?Haemorrhagic diatheses, including coagulation disorders
  • ?Hypersensitivity to ketorolac trometamol or other NSAIDs

Outcomes

Primary Outcomes

Not specified

Similar Trials